Vexev
Develops an autonomous vascular imaging platform that uses robotics and imaging technology to support non-invasive artery scans.
Overview
Vexev builds an autonomous vascular imaging platform for healthcare providers, aiming to improve access to vascular assessment through automated scanning. Its product is positioned for clinical use in non-invasive imaging workflows, with a focus on artery and vascular health. The company raised $6 million in an undisclosed round announced in August 2026. The financing is intended to accelerate U.S. commercialization of its autonomous vascular imaging platform, supporting expansion into a major healthcare market.
Funding History
Vexev Raises $6M to Accelerate U.S. Commercialization of Autonomous Vascular Imaging Platform
Frequently Asked Questions
- How much funding does AI Funding track for Vexev?
- AI Funding tracks $6M for Vexev across 1 funding round in this database.
- What does Vexev do?
- Vexev builds an autonomous vascular imaging platform for healthcare providers, aiming to improve access to vascular assessment through automated scanning. Its product is positioned for clinical use in non-invasive imaging workflows, with a focus on artery and vascular health. The company raised $6 million in an undisclosed round announced in August 2026. The financing is intended to accelerate U.S. commercialization of its autonomous vascular imaging platform, supporting expansion into a major healthcare market.
- Where is Vexev headquartered?
- Vexev is headquartered in Sydney, Australia.
Related Insights
An in-depth analysis of AMD's AI investment portfolio, strategy, co-investors, and sector focus across 3 tracked deals as of August 2026.
A funding-led map of the Physical AI stack, from real-world data and simulation through autonomy models, robotic systems, validation, and deployment infrastructure.
A comprehensive analysis of RoboForce's funding history, investors, competitive position, and growth trajectory in the AI Robotics space.